Limes Schlosskliniken AG: preliminary Half Year Result 2022
|
DGAP-Ad-hoc: Limes Schlosskliniken AG / Key word(s): Half Year Results/Preliminary Results DGAP-Adhoc: Limes Schlosskliniken AG: Positive business development in the first half year 2022
Cologne, 23.08.2022: In the first six months of the current financial year the LIMES Schlosskliniken Group took a big step forward. The services offered at all three clinics were well received by patients. Due to the positive patient response, we were able to significantly increase our occupancy rate in all three clinics. This led to a higher turnover and result compared to the previous year. All three clinics were able to make roughly the same contribution to the overall result. Due to good occupancy in July and August, we expect the third quarter to be the strongest so far. For further expansion, we were able to raise a tranche of debt capital in the amount of EUR 6 million at attractive conditions. Cash and cash equivalents totalled EUR 12.6 million as of 30 June 2022. The new LIMES team for the Lindlar site has been in the training phase since 01.08.2022. Due to various supply problems, the general contractor has postponed the handover of the clinic to 01.11.2022.
We are pleased that the LIMES brand as a service provider stands for a high-quality psychiatric offer in the spectrum of stress-related illness, depression, trauma and personality disorder and is increasingly finding positive resonance in the market. The detailed half-year report of LIMES Schlosskliniken will be published on 15.09.2022.
The LIMES Schlosskliniken Group operates high-quality private clinics in Germany for stress-related illnesses, mental and emotional disorders, such as depression, affective disorders and acute burnout conditions. The range of services is aimed at private patients, those entitled to state aid and self-payers. The LIMES Schlosskliniken Group stands for the special approach of a relationship-oriented medicine in the treatment of people with mental illnesses. In addition to top medical quality, patients are offered a unique, protected and healing environment in which they can recover holistically. Further information is available at www.limes-schlosskliniken.de.
23-Aug-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Limes Schlosskliniken AG |
| Kaiser-Wilhelm-Ring 26 | |
| 50672 Köln | |
| Germany | |
| ISIN: | DE000A0JDBC7 |
| WKN: | A0JDBC |
| Listed: | Regulated Unofficial Market in Dusseldorf |
| EQS News ID: | 1425973 |
| End of Announcement | DGAP News Service |
|
|
1425973 23-Aug-2022 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.